Investing.com - AquaBounty Tech reported on Tuesday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations. AquaBounty Tech announced...
AquaBounty Technologies, Inc. (NASDAQ:AQB) reported Q2 EPS of ($0.08), $0.01 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $1.1 million versus the...
Amicus Therapeutics (NASDAQ:FOLD) announced clinical, regulatory and manufacturing advancements for AT-GAA, its investigational therapy for Pompe disease.The company is utilizing...
AquaBounty Technologies, Inc. (AQB) AQB popped 45 cents on Monday, or 13%, to 3.93, on 470,362 shares traded and took out resistance at the level where it exploded in March. If it...
AquaBounty Technologies, Inc. is engaged in the field of land-based aquaculture. The Company's GE Atlantic salmon is based upon salmon genetics and grows to harvest size faster than conventional Atlantic salmon. It farms its GE Atlantic salmon in land-based, recirculating aquaculture systems (RAS). The closed, contained, land-based production systems using RAS technology that the Company uses for the grow-out of its fish are less susceptible to the disease-related pressures of conventional salmon farming. Its RAS facilities provide water treatment technology, including the use of ozone, salt treatment and ultraviolet radiation to kill potential bacterial, fungal, or viral pathogens, which might enter the system. Its GE Atlantic salmon is based upon a single, specific molecular modification in the fish that results in rapid growth in early development. It has two salmon farms in production, one is located in Indiana and the other located in Prince Edward Island, Canada.
|Average||3.447 (+213.409% Upside)|
|No. of Analysts||4|